USE OF SYNTHESIZED COMPOUNDS AS AN INHIBITOR OF EF2-KINASE ENZYME

The invention is related to the use of synthesized compounds, as an inhibitor of the EF2-Kinase enzyme which is active in breast, pancreas, brain, ovarian, lung, skin (melanoma) and blood cancers. The aim of this invention is to make use of synthesized compounds as an inhibitor of the EF2-Kinase enz...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	COMERT ONDER, Ferah, KANDEMIR, Hakan, SAHINER, Nurettin, BELLUR ATICI, Esen, KARLIGA, Bekir, CAGIR, Ali, OZPOLAT, Bulent, TATAR, Gizem, TASKIN TOK, Tugba, AY, Mehmet
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention is related to the use of synthesized compounds, as an inhibitor of the EF2-Kinase enzyme which is active in breast, pancreas, brain, ovarian, lung, skin (melanoma) and blood cancers. The aim of this invention is to make use of synthesized compounds as an inhibitor of the EF2-Kinase enzyme. L'invention concerne l'utilisation de composés synthétisés, en tant qu'inhibiteur de l'enzyme EF2-kinase qui est active dans le cancer du sein, du pancréas, du cerveau, de l'ovaire, du poumon, de la peau (mélanome) et du sang. Le but de la présente invention est d'utiliser des composés synthétisés en tant qu'inhibiteur de l'enzyme EF2-kinase.